Abstract:
Disclosed herein is a bidirectional alternating application system for preventing or treating a brain tumor caused by malignant glioma cells in animals. The bidirectional alternating magnetic field application system can apply a magnetic field having weak intensity and low frequency to patients in need of the prevention or treatment of brain tumor to thereby specifically inhibit the proliferation and mobility of glioma cells without causing any damage to normal cells. Thus, the bidirectional alternating magnetic field application system can greatly reduce side effects occurring in patients after surgery.
Abstract:
The present invention relates to a semiconductor device and a method for manufacturing the same. Disclosed is a semiconductor device including a substrate, a conductive line on the substrate, and a seed layer between the substrate and the conductive line, the seed layer including cobalt titanium nitride.
Abstract:
A communication network, and a method and device for identifying a node connected to the communication network are disclosed. According to an embodiment of the present disclosure, there is provided a communication network which performs communication using a voltage difference between wires constituting a communication bus, the communication network including: the wires; a first transceiver connected to the wires and including a first resistor across which a portion of a first power supply voltage is distributed; and a second transceiver connected to the wires and including a second resistor across which a portion of a second power supply voltage is distributed, wherein the first resistor has a different value from the second resistor.
Abstract:
The present disclosure relates to an immunosuppressive composition containing 3,6-anhydro-L-galactose (L-AHG) as an active ingredient, and a pharmaceutical composition for preventing or treating immunological diseases, a health functional food for preventing or ameliorating immunological diseases, and a functional cosmetic composition for preventing or ameliorating hypersensitivity skin reactions, which contain the active ingredient. The immunosuppressive composition, pharmaceutical composition, health functional food, and functional cosmetic composition containing L-AHG according to the present disclosure have an excellent effect of selectively and effectively inhibiting the activation, proliferation and differentiation of CD4 T cells, which are the main targets of immunosuppressants, and thus are very useful in the pharmaceutical industry, the food industry and the cosmetic industry.
Abstract:
Provided are a blood biomarker for diagnosis, prognosis prediction, or treatment of Parkinson's disease (PD), a method for diagnosing or predicting the prognosis of PD using the same, and a method for screening substances for treating PD, where it is confirmed that the levels of 14 types of miRNA are significantly increased or decreased in the blood of PD patients, and the 14 types of miRNA reflect the correlation between genes and environmental factors identified in subjects with PD, thus the 14 types of miRNA are expected to be used as a diagnostic and prognostic biomarker as well as a new therapeutic target related to the pathological mechanism of PD.
Abstract:
The present invention relates to a composition for preventing or treating Parkinson's disease comprising AEG-1 (S298D) as an active ingredient, and in the present invention, a point mutation was introduced into AEG-1 to induce a constitutively active form of AEG-1 (S298D), to construct AAV-AEG-1 (S298D), and to apply an animal model for Parkinson's disease, and accordingly, it was confirmed that it exhibits a protective effect on brain tissue by preserving dopaminergic neurons and dopamine nerve fibers and thus AEG-1 is useful as a composition for preventing or treating Parkinson's disease, a health food composition for preventing or improving Parkinson's disease, etc.
Abstract:
An embodiment provides a multi-sensor and an early diagnosis system using the same, wherein the multi-sensor diagnoses a disease by using deep learning technology after obtaining a plurality of different electric signals obtained through reactions with target materials that respectively contact a plurality of sensors equipped in the multi-sensor.
Abstract:
The present invention relates to a biomarker composition for diagnosing and predicting prognosis of prostate cancer, and that the detection rate and expression level of gene combination composed with AR (Androgen receptor), AR-V7 (Androgen receptor variant 7), EpCAM (Epithelial cell adhesion molecule) in blood tumor cells (CTC) isolated from patients, Epithelial cell adhesion molecule), KRT-19 (Cytokeratin 19), PSA (Prostate specific antigen), and PSMA (Prostate specific membrane antigen) in circulating tumor cells (CTCs) isolated from patients is related to the level of malignancy in prostate cancer is confirmed and thus the gene combination provides as a biomarker for prostate cancer diagnosis and a biomarker for prognosis prediction of prostate cancer.
Abstract:
A device transfer apparatus is provided. The device transfer apparatus includes a container of a polygonal shape which contains a substrate including device holes, vibration sources which generates vibration and transfers the vibration to a fluid in the container, and a processor which controls outputs of the vibration sources. The vibration sources include first group vibration sources arranged on a circumference of a first circle having a radius of a first distance from a central point, and second group vibration sources arranged on a circumference of a second circle which is concentric with the first circle and has a radius of a second distance that is longer than the first distance. The container is arranged on the central point and contains a fluid and micro devices distributed in the fluid. The processor controls the first group vibration sources and the second group vibration sources to output vibration.
Abstract:
Provided are a self voice training method for a patient with a voice disorder and a user terminal for self voice training. The user terminal for self voice training includes an input device configured to receive a training program selection command of a user, a storage configured to store voice training candidate programs for the user's voice training, a calculator configured to generate first guide content according to a first voice training program selected from among the voice training candidate programs by the user, an output device configured to output the first guide content, and a microphone configured to receive voice output by the user according to the first guide content output through the output device.